Collection of genomic DNA by the noninvasive mouthwash method for use in pharmacogenetic studies

被引:44
作者
Andrisin, TE
Humma, LM
Johnson, JA
机构
[1] Univ Florida, Dept Pharm Practice, Gainesville, FL 32610 USA
[2] Univ Florida, Ctr Pharmacogenom, Gainesville, FL 32610 USA
来源
PHARMACOTHERAPY | 2002年 / 22卷 / 08期
关键词
D O I
10.1592/phco.22.12.954.33598
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective. To determine long-term stability, quantity, and quality of genomic DNA samples collected in buccal cells by the mouthwash method, for use in pharmacogenetic studies, Design. Prospective analysis. Setting. University pharmacogenomics center in Florida and medical centers in Puerto Rico and the United States participating in a multicenter international trial. Subjects. Ten volunteers at the pharmacogenomics center and 2011 participants in the ongoing multicenter clinical trial. Intervention. Stability of genomic DNA was determined by measuring DNA yield from mouthwash samples obtained from Six Volunteers and stored at room temperature over 90 days and from 201 clinical trial samples that were stored and shipped at room temperature. Whether DNA yield was higher with three 5-ml mouthwash rinses versus one 10-ml rinse was evaluated in four volunteers. Quality, of genomic DNA was assessed on 32 randomly selected samples from the six volunteers in the stability study by determining the success rate of DNA amplification with polymerase chain reaction (PCR) testing and by genotyping. Measurements and Main Results. For the stability studies, the quantity of genomic DNA decreased over time with storage at room temperature (overall p<0.01) with the largest declines occurring at 60 and 90 days. Median DNA recovery at 30 and 90 days was 59% and 28% of that at baseline, respectively. Mean +/- standard deviation, median, and range for recovery of genomic DNA from the 201 samples were 45.2 +/- 55 mug, 25.2 +/- mug, ands 1-330 mug, respectively. Median recoveries of DNA from the one-rinse and three-rinse methods were not statistically significantly different (9.1 vs 10.5 mug). All samples were amplified successfully by PCR and genotyped, indicating quality of the DNA samples. Conclusion. The mouthwash method for collection of genomic DNA is a simple, inexpensive, and noninvasive method that poses less risk than venipuncture and may be used in a variety; of settings, Genomic DNA in mouthwash is stable for prolonged periods at room temperature, and the quantity of DNA recovered from this method is more than sufficient for pharmacogenetic studies. Such an approach should be valuable to pharmacogenetic researchers and others who are conducting genetic research.
引用
收藏
页码:954 / 960
页数:7
相关论文
共 8 条
  • [1] Pharmacogenomics: The inherited basis for interindividual differences in drug response
    Evans, WE
    Johnson, JA
    [J]. ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2001, 2 : 9 - 39
  • [2] Feigelson HS, 2001, CANCER EPIDEM BIOMAR, V10, P1005
  • [3] García-Closas M, 2001, CANCER EPIDEM BIOMAR, V10, P687
  • [4] UTILITY OF A SWISH AND SPIT TECHNIQUE FOR THE COLLECTION OF BUCCAL CELLS FOR TAP HAPLOTYPE DETERMINATION
    HAYNEY, MS
    DIMANLIG, P
    LIPSKY, JJ
    POLAND, GA
    [J]. MAYO CLINIC PROCEEDINGS, 1995, 70 (10) : 951 - 954
  • [5] Heath EM, 2001, ARCH PATHOL LAB MED, V125, P127
  • [6] Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia
    Humma, LM
    Puckett, BJ
    Richardson, HE
    Terra, SG
    Andrisin, TE
    Lejeune, BL
    Wallace, MR
    Lewis, JF
    McNamara, DM
    Picoult-Newberg, L
    Pepine, CJ
    Johnson, JA
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (09) : 1034 - +
  • [7] Le Marchand L, 2001, CANCER EPIDEM BIOMAR, V10, P701
  • [8] Lum A, 1998, CANCER EPIDEM BIOMAR, V7, P719